神戸大学附属図書館デジタルアーカイブ
登録はこちら
入力補助
English
カテゴリ
学内刊行物
ランキング
アクセスランキング
ダウンロードランキング
https://hdl.handle.net/20.500.14094/0100482728
このアイテムのアクセス数:
218
件
(
2026-04-03
01:54 集計
)
閲覧可能ファイル
ファイル
フォーマット
サイズ
閲覧回数
説明
0100482728 (fulltext)
pdf
922 KB
270
メタデータ
ファイル出力
メタデータID
0100482728
アクセス権
open access
出版タイプ
Accepted Manuscript
タイトル
Amentoflavone inhibits hepatitis B virus infection via the suppression of preS1 binding to host cells
著者
Aoki-Utsubo, Chie ; Indrasetiawan, Puguh ; Fukano, Kento ; Muramatsu, Masamichi ; Artanti, Nina ; Hanafi, Muhammad ; Hotta, Hak ; Kameoka, Masanori
著者ID
A0814
研究者ID
1000050570834
KUID
https://kuid-rm-web.ofc.kobe-u.ac.jp/search/detail?systemId=78f934f4b4bf5861520e17560c007669
著者名
Aoki-Utsubo, Chie
靭, 千恵
ウツボ, チエ
所属機関名
保健学研究科
著者名
Indrasetiawan, Puguh
著者名
Fukano, Kento
著者名
Muramatsu, Masamichi
著者名
Artanti, Nina
著者名
Hanafi, Muhammad
著者ID
A0749
研究者ID
1000040116249
著者名
Hotta, Hak
堀田, 博
ホツタ, ハク
所属機関名
保健学研究科
著者ID
A0045
研究者ID
1000060281838
ORCID
0000-0001-5525-9915
KUID
https://kuid-rm-web.ofc.kobe-u.ac.jp/search/detail?systemId=01cae9e1f2290a00520e17560c007669
著者名
Kameoka, Masanori
亀岡, 正典
カメオカ, マサノリ
所属機関名
保健学研究科
言語
English (英語)
収録物名
Microbiology and Immunology
巻(号)
67(6)
ページ
281-292
出版者
John Wiley & Sons
刊行日
2023-06
公開日
2024-04-04
抄録
Hepatitis B virus (HBV) is a leading cause of chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma. Current therapeutic drugs for chronic HBV infection use IFN and nucleos(t)ide analogs; however, their efficacy is limited. Thus, there is an urgent need to develop new antivirals for HBV therapy. In this study, we identified a plant-derived polyphenolic bioflavonoid, amentoflavone, as a new anti-HBV compound. Amentoflavone treatment dose-dependently inhibited HBV infection in HBV-susceptible cells with HepG2-hNTCP-C4 and primary human hepatocyte PXB-cells. A mode-of-action study showed that amentoflavone inhibits the viral entry step, but not the viral internalization and early replication processes. Attachment of HBV particles as well as HBV preS1 peptide to HepG2-hNTCP-C4 cells was inhibited by amentoflavone. The transporter assay revealed that amentoflavone partly inhibits uptake of sodium taurocholate cotransporting polypeptide (NTCP)–mediated bile acid. Furthermore, effect of various amentoflavone analogs on HBs and HBe production from HBV-infected HepG2-hNTCP-C4 cells was examined. Robustaflavone exhibited comparable anti-HBV activity to that of amentoflavone and an amentoflavone-7,4', 4‴-trimethyl ether derivative (sciadopitysin) with moderate anti-HBV activity. Cupressuflavone or the monomeric flavonoid apigenin did not exhibit the antiviral activity. Amentoflavone and its structurally related biflavonoids may provide a potential drug scaffold in the design of a new anti-HBV drug inhibitor targeting NTCP.
キーワード
amentoflavone
antiviral
attachment
hepatitis B virus (HBV)
viral entry
カテゴリ
保健学研究科
学術雑誌論文
権利
This is the peer reviewed version of the following article: [Aoki-Utsubo, C, Indrasetiawan, P, Fukano, K, et al. Amentoflavone inhibits hepatitis B virus infection via the suppression of preS1 binding to host cells. Microbiol Immunol. 2023; 67: 281–292.], which has been published in final form at [https://doi.org/10.1111/1348-0421.13064]. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Use of Self-Archived Versions. This article may not be enhanced, enriched or otherwise transformed into a derivative work, without express permission from Wiley or by statutory rights under applicable legislation. Copyright notices must not be removed, obscured or modified. The article must be linked to Wiley’s version of record on Wiley Online Library and any embedding, framing or otherwise making available the article or pages thereof by third parties from platforms, services and websites other than Wiley Online Library must be prohibited.
関連情報
DOI
https://doi.org/10.1111/1348-0421.13064
詳細を表示
資源タイプ
journal article
ISSN
0385-5600
OPACで所蔵を検索
CiNiiで学外所蔵を検索
eISSN
1348-0421
OPACで所蔵を検索
CiNiiで学外所蔵を検索
ホームへ戻る